Skip to Content

Pfizer STN 12.5 mg (Sutent 12.5 mg)

Generic Name: sunitinib

Pill with imprint Pfizer STN 12.5 mg is Orange, Capsule-shape and has been identified as Sutent 12.5 mg. It is supplied by Pfizer U.S. Pharmaceuticals Group.

Sutent is used in the treatment of renal cell carcinoma; gastrointestinal stromal tumor; pancreatic cancer and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Sutent 12.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Pfizer STN 12.5 mg

Sutent

Generic Name:
sunitinib
Imprint:
Pfizer STN 12.5 mg
Strength:
12.5 mg
Color:
Orange
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Multikinase inhibitors
VEGF/VEGFR inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Pfizer U.S. Pharmaceuticals Group
Inactive Ingredients:
mannitol
croscarmellose sodium
povidone k25
magnesium stearate
gelatin
titanium dioxide
ferric oxide red
shellac
propylene glycol
sodium hydroxide
povidone
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide